What is it about?
This is a brief review that the summarizes the current state of using stem cells for understanding heart diseases, and for drug screening for toxicological and drug development purposes. In addition, the current challenges of the technology are discussed, and future strategies that would enable to gain deeper and wider knowledge are suggested.
Featured Image
Read the Original
This page is a summary of: Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing, Clinical Pharmacology & Therapeutics, July 2017, Wiley,
DOI: 10.1002/cpt.722.
You can read the full text:
Contributors
The following have contributed to this page







